(2016) : Published in the New England Journal of Medicine, this landmark paper reported the cardiovascular outcomes of the SUSTAIN-6 trial, providing critical evidence of semaglutides cardiovascular benefits
Cangui-Panchi SP, acato-Toapanta AL, Enrquez-Martnez LJ, Salinas-Delgado GA, Reyes J, Garzon-Chavez D
Collaborations and pharma partnerships for obesity drug development are accelerating innovation, combining expertise to bring next-generation therapies to market faster
Keep an eye on your appetite, cravings, and weight to determine if the pace is right
GLP-1 receptor agonists, targeting the entero-insular axis, mimic the insulin-boosting effects of bariatric surgery
METROPRESS XL 2.5 TABLET - PRAZOSIN HYDROCHLORIDE 5MG EXTENDED RELEASE TABLET METROPRESS XL 5 TABLET - PRAZOSIN HYDROCHLORIDE 5MG EXTENDED RELEASE TABLET METROSIN R 2.5 TABLET - METOPROLOL SUCCONATE (SR) 25MG & RAMIPRIL 2.5MG TABLET METROSIN R 2.5 TABLET -METOPROLOL SUCCONATE (SR) 25MG & RAMIPRIL 2.5MG TABLET METROSIN XL 100 TABLETS - Each Film Coated Extended Releaser Tablet Contains : Metoprolol Succinate Ip 95mg Eq To Metoprolol Tartrate 100 Mg METROSIN XL 25 TAB 20X10 - Metoprolol Succinate (25mg) METROSIN XL 50 TAB 10X10 METROSIN XL 50 TABLET 20X10 - Each Film Coated Extended Release Tablet Contains : Metoprolol Succinate Ip - 47.50 Mg, Eq